Francine ratner kaufman type 1 diabetes mellitus treatment management involves improved insulin preparations, insulin delivery systems, glucose and ketone monitoring, and laboratory assessment. Dr. Francine Ratner Kaufman, MD, is a professor and head of Center for Diabetes, Endocrinology and Metabolism at Children’s Hospital Los Angeles. She was also elected to The AOA Honorary Medical Society. The 2002 LA County Task force on the Fitness and Health and Fitness was chaired by her. She was also a delegate at the 2002 55th Assembly of the World Health Organization. Dr. Kaufman is chairperson of the NIH-funded STOPP-T2 trials.
Trail Net- the NIH study is trying to put a stop to Type 1 diabetes and preserve beta cell functions. Dr. Kaufman has been active on various committees of the National Institutes of Health. Dr. Kaufman’s other research interests are: Outcome of childhood diabetes, Neurocognitive outcome in diabetes, T-Cell studies in type I diabetes and pre diabetes, prevention of type I diabetes mellitus, Glycemic control and outcome, Nucleotide sugar metabolism, CD Rom teaching module in diabetes, Prevention of hypoglycemia, use of cornstarch – cornstarch bars, Cerebral edema and strokes in DKA and Macrovascular complications.
Type 1 diabetes mellitus occurs owing to complete insulin deficiency. Auto-immune damage of beta cells of the pancreas causes it. Certain viruses and chemical toxins, specific immune factors and genetic weakness are the risk factors for the development of type 1 auto-immune diabetes. Amongst children and adolescents who have francine ratner kaufman type 1 diabetes mellitus the most important factor for sickness and death is diabetic ketoacidosis. This is treated by improvement in the availability of fluids and correcting electrolyte disorder along with release of cautiously managed insulin. The main difficulty in treatment is cerebral edema.
The hallmark of diabetes is hyperglycemia. Life-threatening troubles, such as vascular collapse, acute electrolyte disturbance and cerebral edema can result on account of intense hyperglycemia with ketoacidosis. Long – term problems can injure various organs, including the heart, nerves, kidneys, eyes and blood vessels due to persistent increase of blood glucose levels. Type 1 diabetes mellitus management is a long-term process. This comprises of administration of two or more insulin injections per day, multiple blood glucose measurements, balancing of food and exercise and adjustment of insulin dosage.
The insulin course of therapy for francine ratner kaufman type 1 diabetes mellitus depends on the child’s age and its developmental stage. The insulin dosage is adjusted taking into consideration changes in exercise and movements. The results of a study to see the correlation between Diabetes Control and Complications revealed a noteworthy decline in mean blood glucose levels, glycated hemoglobin concentrations, and diabetic complications. This was in those who received extensive supervision compared with those who received moderate supervision. However, there was a higher risk of acute hypoglycemia in the former group. Long-term problems can take place that injure various organs including the heart, nerves, kidneys, eyes and blood vessels due to persistent increase of blood glucose levels. Currently there is no way to screen for or prevent the development of type 1 diabetes mellitus. Many people with type 1 diabetes live long, healthy lives. To control their blood sugar all people with type 1 diabetes mellitus must use insulin injections.